AiCuris Anti-infective Cures AG is a pharmaceutical company based in Germany, specializing in the discovery, research, and development of novel antiviral and antibacterial agents. The company focuses on creating treatments for severe and potentially life-threatening infectious diseases, particularly for immunocompromised patients. Spun off from Bayer in 2006, AiCuris has successfully developed and out-licensed products, such as Letermovir (Prevymis®), and maintains an innovative pipeline of anti-infectives.